Home NDC 0002-7797-61 EBGLYSS
Product NDC 0002-7797
Requested package NDC 0002-7797-61
11-digit product format 000027797
Labeler code 0002
Product ID 0002-7797_190124d7-2239-400c-8580-ffb0358c1d6d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name lebrikizumab-lbkz
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Eli Lilly and Company
Application BLA761306
Marketing category BLA
Marketing start 2024-09-13
Substance LEBRIKIZUMAB
Active strength 250 mg/2mL
Pharmacologic classes Interleukin-13 Antagonist [EPC], Interleukin-13 Antagonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base EBGLYSS
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LEBRIKIZUMAB 250 mg/2mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0002-7797-01 EBGLYSS 2 mL in 1 SYRINGE INJECTION, SOLUTION 2 12 0002-7797-11 EBGLYSS 1 in 1 CARTON INJECTION, SOLUTION 1 12 0002-7797-61 EBGLYSS 2 mL in 1 SYRINGE INJECTION, SOLUTION 2 12 0002-7797-61 EBGLYSS 1 in 1 CARTON INJECTION, SOLUTION 1 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0002-7797 EBGLYSS (LEBRIKIZUMAB-LBKZ) INJECTION, SOLUTION [ELI LILLY AND COMPANY] 6 Current NDC, 4 package rows 20250212_7a774ea2-acde-4aaa-9a8f-ccba5a5b1d5f.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761306 Ebglyss lebrikizumab-lbkz 351(a) Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0002-7797-61 00002779761 1 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGE 1 syringe 2024-09-13 Yes No Current